LIQUIDIA CORPORATION Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $1.44M, a 1054.40% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $773.00K, a 115.92% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $1.55M, a 0.26% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $125.00K, a 290.63% increase year-over-year.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for fiscal 2025 was $2.97M, a 67.76% increase from fiscal 2024.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for fiscal 2024 was $1.77M, a 257.78% increase from fiscal 2023.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for fiscal 2023 was $495.00K, a 40.93% decline from fiscal 2022.
- LIQUIDIA CORPORATION stock issued during period, value, stock options exercised for fiscal 2022 was $838.00K, a 1943.90% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $1.44M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $773.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $2.97M 10-K · filed 2026-03-05 | |
| 2025-09-30 | $1.55M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $125.00K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $358.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $1.77M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $1.55M 10-Q · filed 2025-11-03 | |
| 2024-06-30 | $32.00K 10-Q · filed 2025-11-03 | |
| 2024-03-31 | $99.00K 10-Q · filed 2025-11-03 | |
| 2023-12-31 | $495.00K 10-K · filed 2026-03-05 | |
| 2023-09-30 | $304.00K 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $32.00K 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $79.00K 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $838.00K 10-K · filed 2024-03-13 | |
| 2022-09-30 | $141.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $593.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $41.00K 10-K · filed 2023-03-20 | |
| 2021-03-31 | $494.00 10-Q · filed 2021-11-03 | |
| 2020-12-31 | $67.92K 10-K · filed 2022-03-17 | |
| 2020-09-30 | $273.00 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $25.65K 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-11-03 | |
| 2019-12-31 | $141.33K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |